Chapter 15. Rare Cancers

  1. Janusz Jankowski MD, PhD, FRCP, FACG Consultant Gastroenterologist Fellow Professor10,11,12,13,14,
  2. Richard Sampliner MD Professor of Medicine Chief of Gastroenterology15,16,
  3. David Kerr CBE, MA, MD, DSc, FRCP, FMedSci Head of Department of Clinical Pharmacology14,17,18 and
  4. Yuman Fong MD Professor of Surgery19,20
  1. Colin McArdle FRCS1,
  2. Irwin M. Modlin MD, PhD, DSC, FRCS2,
  3. Jon Bornschein MD3,
  4. Mark Kidd PhD3,
  5. Gary N. Mann MBBCh, FACS4,
  6. Shailender Bhatia MBBS5,
  7. John L. Thompson MD6,
  8. Matthew Clark MBChB, MD, FRACS7,
  9. Lincoln Israel BHB, MBChB, FRACS8,
  10. Paul H. Sugarbaker MD9 and
  11. Tristan D. Yan BSc, MBBS9

Published Online: 14 JAN 2009

DOI: 10.1002/9781444300147.ch15

Gastrointestinal Oncology: A Critical Multidisciplinary Team Approach

Gastrointestinal Oncology: A Critical Multidisciplinary Team Approach

How to Cite

McArdle, C., Modlin, I. M., Bornschein, J., Kidd, M., Mann, G. N., Bhatia, S., Thompson, J. L., Clark, M., Israel, L., Sugarbaker, P. H. and Yan, T. D. (2008) Rare Cancers, in Gastrointestinal Oncology: A Critical Multidisciplinary Team Approach (eds J. Jankowski, R. Sampliner, D. Kerr and Y. Fong), Blackwell Publishing Ltd., Oxford, UK. doi: 10.1002/9781444300147.ch15

Editor Information

  1. 10

    Digestive Diseases Centre UHL Trust, Leicester, UK

  2. 11

    James Black Senior Fellow and Professor, University of Oxford, UK

  3. 12

    Cancer Research, UK

  4. 13

    Queen Mary University of London, UK

  5. 14

    Department of Clinical Pharmacology, University of Oxford, Oxford, UK

  6. 15

    University of Arizona College of Medicine, Tuscon, AZ, USA

  7. 16

    Southern Arizona VA Health Care System, USA

  8. 17

    Rhodes Professor of Cancer Therapeutics and Clinical Pharmacology, University of Oxford, UK

  9. 18

    University of Oxford, UK

  10. 19

    Murray F. Brennan Chair in Surgery, Memorial Sloan-Kettering Cancer Center, New York, USA

  11. 20

    Weill Cornell Medical Center, New York, USA

Author Information

  1. 1

    Department of Surgery, Royal Infirmary, Glasgow, UK

  2. 2

    Yale University School of Medicine, New Haven, CT, USA

  3. 3

    Department of Gastroenterological Surgery, Yale University School of Medicine, New Haven, CT, USA

  4. 4

    Department of Surgery, Section of Surgical Oncology, University of Washington Medical Center, Seattle, WA, USA

  5. 5

    Division of Hematology-Oncology, Fred Hutchinson Cancer Research Center, University of Washington, Seattle, WA, USA

  6. 6

    Fred Hutchinson Cancer Research Center, University of Washington, Seattle, WA, USA

  7. 7

    University of Auckland, Auckland, New Zealand

  8. 8

    Middlemore Hospital, Otahuhu, Auckland, New Zealand

  9. 9

    Peritoneal Surface Malignancy Program, Washington Cancer Institute, Washington Hospital Center, Washington, DC, USA

Publication History

  1. Published Online: 14 JAN 2009
  2. Published Print: 11 APR 2008

ISBN Information

Print ISBN: 9781405127837

Online ISBN: 9781444300147

SEARCH

Keywords:

  • rare cancers;
  • neuroendocrine tumors (NETs = carcinoids);
  • symptomatic therapy for carcinoid disease and SST analogs;
  • hypergastrinemia-associated carcinoids;
  • anorectal melanomas (ARM);
  • pseudomyxoma peritonei syndrome;
  • perioperative intraperitoneal chemotherapy

Summary

This chapter contains sections titled:

  • Gastrointestinal carcinoids

  • Anorectal melanoma

  • Cancer of the anal canal

  • Appendiceal epithelial neoplasms

  • Diffuse malignant peritoneal mesothelioma

  • References